Related Experiment Video
Updated: May 10, 2026
13:50
Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Thrombocytopenia in HIV-Infected Patients.
Francielle Garcia Nascimento1, Paula Yurie Tanaka
1Hematology Section, Instituto de Infectologia Emílio Ribas, Av. Dr. Arnaldo, 165, São Paulo, SP 01246-900 Brazil.
Summary
Thrombocytopenia remains common in HIV patients, often immune-related. Highly active antiretroviral therapy (HAART) can help manage platelet counts, but further diagnostic approaches are needed for effective treatment.
Area of Science:
- Hematology
- Infectious Diseases
- Immunology
Background:
- Thrombocytopenia is a frequent complication in Human Immunodeficiency Virus (HIV)-positive individuals.
- Limited data exists on thrombocytopenia management following the introduction of highly active antiretroviral therapy (HAART).
Purpose of the Study:
- To describe the epidemiology, clinical features, and treatment outcomes of thrombocytopenia in HIV-positive outpatients.
- To investigate the role of HAART in managing thrombocytopenia in this population.
Main Methods:
- Retrospective analysis of 55 HIV-positive outpatients with thrombocytopenia from two reference centers in São Paulo, Brazil.
- Data collection included patient demographics, CD4+ T-cell counts, causes of thrombocytopenia, HAART usage, and treatment interventions.
Main Results:
- The study population (n=55) comprised 62% males, 91% Caucasian, with a median CD4+ T-cell count of 394 cells/mm³.
- Immune thrombocytopenic purpura was the primary cause (63.6%), followed by non-immune causes (25.5%).
- 43.6% used HAART regularly; 20% initiated HAART for thrombocytopenia, showing platelet count improvement within 3 months. Platelet transfusions were required in 23.7%, and one patient died from bleeding.
Conclusions:
- Thrombocytopenia persists as a common, multifactorial disorder in HIV-infected patients, frequently driven by immune mechanisms.
- HAART can be beneficial for managing thrombocytopenia, but a comprehensive diagnostic strategy targeting HIV-related hematological effects is crucial for optimal patient care.
Related Concept Videos
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...